142 related articles for article (PubMed ID: 37879354)
1. Desmopressin Dose Requirements in Adults with Congenital and Acquired Central Diabetes Insipidus.
Pedersen AN; Andreassen M; Rasmussen AK; Krogh J
Horm Metab Res; 2024 Mar; 56(3):206-213. PubMed ID: 37879354
[TBL] [Abstract][Full Text] [Related]
2. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
[TBL] [Abstract][Full Text] [Related]
3. Variability in Oral Desmopressin Dose Requirements in Children with Central Diabetes Insipidus.
Almutlaq N; Eugster EA
J Pediatr; 2021 Dec; 239():228-230. PubMed ID: 34487771
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.
Arima H; Oiso Y; Juul KV; Nørgaard JP
Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987
[TBL] [Abstract][Full Text] [Related]
5. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
[TBL] [Abstract][Full Text] [Related]
6. Desmopressin administration in children with central diabetes insipidus: a retrospective review.
Ooi HL; Maguire AM; Ambler GR
J Pediatr Endocrinol Metab; 2013; 26(11-12):1047-52. PubMed ID: 23843580
[TBL] [Abstract][Full Text] [Related]
7. Severe water intoxication secondary to the concomitant intake of non-steroidal anti-inflammatory drugs and desmopressin: a case report and review of the literature.
Verrua E; Mantovani G; Ferrante E; Noto A; Sala E; Malchiodi E; Iapichino G; Peccoz PB; Spada A
Hormones (Athens); 2013; 12(1):135-41. PubMed ID: 23624139
[TBL] [Abstract][Full Text] [Related]
8. Desmopressin orally disintegrating tablet in Japanese patients with central diabetes insipidus: a retrospective study of switching from intranasal desmopressin.
Murakami T; Hatoko T; Nambu T; Matsuda Y; Matsuo K; Yonemitsu S; Muro S; Oki S
Endocr J; 2014; 61(8):773-9. PubMed ID: 24849384
[TBL] [Abstract][Full Text] [Related]
9. Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
Korkmaz HA; Arya VB; Gönüllü A; Coşkunol F; Ozkan B
Paediatr Drugs; 2023 Sep; 25(5):595-601. PubMed ID: 37326929
[TBL] [Abstract][Full Text] [Related]
10. Demyelination syndrome due to rapid correction of desmopressin-associated hyponatremia in a known case of central diabetes insipidus: a case report.
Nabaei G; Abdi S; Fatehi F
Acta Neurol Belg; 2015 Dec; 115(4):819-21. PubMed ID: 25777520
[No Abstract] [Full Text] [Related]
11. [Treatment with sublingual desmopressin in two infants with hydranencephaly and central diabetes insipidus].
Marín GR; Baspineiro B; Vilca I
Arch Argent Pediatr; 2018 Feb; 116(1):e93-e97. PubMed ID: 29333830
[TBL] [Abstract][Full Text] [Related]
12. The risk of hyponatremia with desmopressin use for nocturnal polyuria.
Choi EY; Park JS; Kim YT; Park SY; Kim GH
Am J Nephrol; 2015; 41(3):183-90. PubMed ID: 25871541
[TBL] [Abstract][Full Text] [Related]
13. National Surveillance of Central Diabetes Insipidus (CDI) in Denmark: results from 5 years registration of 9309 prescriptions of desmopressin to 1285 CDI patients.
Juul KV; Schroeder M; Rittig S; Nørgaard JP
J Clin Endocrinol Metab; 2014 Jun; 99(6):2181-7. PubMed ID: 24527719
[TBL] [Abstract][Full Text] [Related]
14. Severe hyponatremia due to desmopressin.
Kelleher HB; Henderson SO
J Emerg Med; 2006 Jan; 30(1):45-7. PubMed ID: 16434334
[TBL] [Abstract][Full Text] [Related]
15. [Desmopressin for nocturia in the old: an inappropriate treatment due to the high risk of side-effects?].
ten Doesschate T; Reichert LJ; Claassen JA
Tijdschr Gerontol Geriatr; 2010 Dec; 41(6):256-61. PubMed ID: 21229778
[TBL] [Abstract][Full Text] [Related]
16. Gender difference in antidiuretic response to desmopressin.
Juul KV; Klein BM; Sandström R; Erichsen L; Nørgaard JP
Am J Physiol Renal Physiol; 2011 May; 300(5):F1116-22. PubMed ID: 21367921
[TBL] [Abstract][Full Text] [Related]
17. [Persistent central diabetes insipidus in a very low birth weight infant].
Quetin F; Garnier H; Brauner R; Vodovar M; Magny JF
Arch Pediatr; 2007 Nov; 14(11):1321-3. PubMed ID: 17916426
[TBL] [Abstract][Full Text] [Related]
18. Comments on "Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study"--efficacy and safety of orally disintegrating desmopressin tablets in patients with central diabetes insipidus.
Kamoi K
Endocr J; 2013; 60(9):1115. PubMed ID: 23863202
[No Abstract] [Full Text] [Related]
19. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
Smego AR; Backeljauw P; Gutmark-Little I
J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
[TBL] [Abstract][Full Text] [Related]
20. Clinical Factors Affecting Daily Dosage of Desmopressin Orally Disintegrating Tablets in Arginine Vasopressin Deficiency.
Hoshino Y; Inoue K; Ikeda S; Goshima Y; Tatsushima K; Fukuhara N; Okada M; Nishioka H; Yamada S; Takeuchi Y; Takeshita A
J Clin Endocrinol Metab; 2024 Feb; 109(3):e983-e996. PubMed ID: 38019190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
